120 related articles for article (PubMed ID: 10811985)
1. beta-catenin mutations are absent in hepatocellular carcinomas of SV40 T-antigen transgenic mice.
Umeda T; Yamamoto T; Kajino K; Hino O
Int J Oncol; 2000 Jun; 16(6):1133-6. PubMed ID: 10811985
[TBL] [Abstract][Full Text] [Related]
2. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas.
de La Coste A; Romagnolo B; Billuart P; Renard CA; Buendia MA; Soubrane O; Fabre M; Chelly J; Beldjord C; Kahn A; Perret C
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8847-51. PubMed ID: 9671767
[TBL] [Abstract][Full Text] [Related]
3. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.
Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W
Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426
[TBL] [Abstract][Full Text] [Related]
4. CTNNB1 mutations and beta-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1.
Devereux TR; Stern MC; Flake GP; Yu MC; Zhang ZQ; London SJ; Taylor JA
Mol Carcinog; 2001 Jun; 31(2):68-73. PubMed ID: 11429783
[TBL] [Abstract][Full Text] [Related]
5. Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis.
Devereux TR; Anna CH; Foley JF; White CM; Sills RC; Barrett JC
Oncogene; 1999 Aug; 18(33):4726-33. PubMed ID: 10467420
[TBL] [Abstract][Full Text] [Related]
6. Tumor heterogeneity in small hepatocellular carcinoma: analysis of tumor cell proliferation, expression and mutation of p53 AND beta-catenin.
An FQ; Matsuda M; Fujii H; Tang RF; Amemiya H; Dai YM; Matsumoto Y
Int J Cancer; 2001 Aug; 93(4):468-74. PubMed ID: 11477549
[TBL] [Abstract][Full Text] [Related]
7. Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice.
Calvisi DF; Factor VM; Ladu S; Conner EA; Thorgeirsson SS
Gastroenterology; 2004 May; 126(5):1374-86. PubMed ID: 15131798
[TBL] [Abstract][Full Text] [Related]
8. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
Calvisi DF; Factor VM; Loi R; Thorgeirsson SS
Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770
[TBL] [Abstract][Full Text] [Related]
9. Beta-catenin and cyclin D1 expression in human hepatocellular carcinoma.
Ueta T; Ikeguchi M; Hirooka Y; Kaibara N; Terada T
Oncol Rep; 2002; 9(6):1197-203. PubMed ID: 12375019
[TBL] [Abstract][Full Text] [Related]
10. Suppression of beta-catenin mutation by dietary exposure of auraptene, a citrus antioxidant, in N,N-diethylnitrosamine-induced hepatocellular carcinomas in rats.
Hara A; Sakata K; Yamada Y; Kuno T; Kitaori N; Oyama T; Hirose Y; Murakami A; Tanaka T; Mori H
Oncol Rep; 2005 Aug; 14(2):345-51. PubMed ID: 16012713
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of orphan G-protein-coupled receptor, Gpr49, in human hepatocellular carcinomas with beta-catenin mutations.
Yamamoto Y; Sakamoto M; Fujii G; Tsuiji H; Kenetaka K; Asaka M; Hirohashi S
Hepatology; 2003 Mar; 37(3):528-33. PubMed ID: 12601349
[TBL] [Abstract][Full Text] [Related]
12. Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations.
Harada N; Oshima H; Katoh M; Tamai Y; Oshima M; Taketo MM
Cancer Res; 2004 Jan; 64(1):48-54. PubMed ID: 14729607
[TBL] [Abstract][Full Text] [Related]
13. beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance.
Wong CM; Fan ST; Ng IO
Cancer; 2001 Jul; 92(1):136-45. PubMed ID: 11443619
[TBL] [Abstract][Full Text] [Related]
14. Close correlation between beta-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomas.
Terris B; Pineau P; Bregeaud L; Valla D; Belghiti J; Tiollais P; Degott C; Dejean A
Oncogene; 1999 Nov; 18(47):6583-8. PubMed ID: 10597262
[TBL] [Abstract][Full Text] [Related]
15. Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver.
Kim Y; Sills RC; Houle CD
Toxicol Pathol; 2005; 33(1):175-80. PubMed ID: 15805069
[TBL] [Abstract][Full Text] [Related]
16. Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3.
Miyoshi Y; Iwao K; Nagasawa Y; Aihara T; Sasaki Y; Imaoka S; Murata M; Shimano T; Nakamura Y
Cancer Res; 1998 Jun; 58(12):2524-7. PubMed ID: 9635572
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
[TBL] [Abstract][Full Text] [Related]
18. Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis.
Park JY; Park WS; Nam SW; Kim SY; Lee SH; Yoo NJ; Lee JY; Park CK
Liver Int; 2005 Feb; 25(1):70-6. PubMed ID: 15698401
[TBL] [Abstract][Full Text] [Related]
19. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
[TBL] [Abstract][Full Text] [Related]
20. Beta-catenin accumulation and mutation of exon 3 of the beta-catenin gene in hepatocellular carcinoma.
Jpn J Cancer Res; 1999 Dec; 90(12):inside front cover. PubMed ID: 10665642
[No Abstract] [Full Text] [Related]
[Next] [New Search]
